Abstract
The cellular mechanisms following myocardial infarction remain poorly characterized. It is believed that an inflammatory and immunologic process may be involved and that the beneficial effects of enalapril on remodeling may, in part, work through an immune mechanism. To characterize the effect of enalapril on immune alterations in the late phase of ventricular remodeling after myocardial infarction, rats underwent left coronary artery ligation followed by 6 weeks of either enalapril or placebo treatment. Infarct sizes, heart weights, and volumes were compared. Peripheral and splenic leukocyte and lymphocyte subsets, along with T cell blastogenesis, were quantified in enalapril treated rats 6 weeks after coronary ligation and compared to untreated control rats. Additionally, antibody production to a de novo antigen, keyhole limpet hemocyanin, was assessed with and without treatment. Average infarct size was equivalent among enalapril-treated myocardial infarction rats and untreated infarct rats. There was, however, less left and right ventricular hypertrophy in the enalapril treated group. Enalapril completely prevented the 42% increase in white blood count, the 88% increase in neutrophils, and the 28% increase in lymphocyte cou...Continue Reading
References
Jan 1, 1978·International Archives of Allergy and Applied Immunology·C G AgrawalS Gupta
Jul 1, 1979·The American Journal of Cardiology·W B KannelP M McNamara
Jun 1, 1978·Chest·M C FishbeinP R Maroko
Jul 1, 1992·Circulation·D R MurrayA S Maisel
Sep 13, 1992·The New England Journal of Medicine·M A PfefferG C Flaker
Nov 18, 1991·The American Journal of Cardiology·J L RouleauF Sestier
Nov 1, 1990·The Journal of Clinical Investigation·Y MagnussonJ Hoebeke
Nov 18, 1991·The American Journal of Cardiology·S E LitwinS Goldman
Nov 18, 1991·The American Journal of Cardiology·E Braunwald, M A Pfeffer
Aug 1, 1991·European Heart Journal·I K De ScheerderR Wieme
Feb 1, 1990·The Journal of Clinical Investigation·A S MaiselM C Michel
Dec 1, 1990·Circulation·A S MaiselM C Michel
Jun 1, 1990·Journal of the American College of Cardiology·A L CaforioW J McKenna
Oct 1, 1990·Journal of the American College of Cardiology·R G Gay
Nov 1, 1990·Journal of the American College of Cardiology·D A NeumannA Herskowitz
Jun 1, 1990·Journal of the American College of Cardiology·J L DinermanA Davidson
Jul 1, 1990·Circulation Research·G OlivettiP Anversa
Dec 1, 1987·Journal of Cardiovascular Pharmacology·C S SweetL G Ribeiro
Jan 1, 1989·Circulation Research·C J LimasC Limas
Feb 1, 1989·Circulation Research·K SchulzeH P Schultheiss
Mar 1, 1989·Circulation·S M HeilbrunnM B Fowler
May 1, 1989·The American Journal of Cardiology·C J LimasC Limas
Sep 1, 1989·Circulation·A S MaiselS M Carter
Sep 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·T GulickG F Schreiner
Jun 1, 1989·American Heart Journal·P G WolffH P Schultheiss
Jan 1, 1989·British Journal of Clinical Pharmacology·K T Weber, J S Janicki
Jan 17, 1985·The New England Journal of Medicine·J M McCord
Apr 1, 1988·Circulation·M Packer
Jul 11, 1988·The American Journal of Cardiology·G S Francis
Jul 11, 1988·The American Journal of Cardiology·J N Cohn, T S Rector
Jul 1, 1987·Circulation·H D WhiteC J Wild
Jul 22, 1982·The New England Journal of Medicine·M R BristowE B Stinson
Nov 1, 1983·The American Journal of Cardiology·B MaischK Kochsiek
Sep 1, 1981·Circulation Research·P J FletcherE Braunwald